Life Science Business
From Clarification of Life Processes to Next-Generation Medical Care
The business of the Life Science Group covers a broad range of fields spanning basic research and clinical medicine-from advanced microscope systems for use in clarification of life processes to diagnostic systems useful in early detection of lifestyle diseases, as well as genetic and protein analysis systems indispensable to the realization of personalized medicine, which aims to provide optimal preventive and treatment techniques for individuals. Olympus is strengthening ties with advanced research institutes in its active pursuit and support of innovative technological developments. Within the Cancer Chemotherapy Center of the Japanese Foundation for Cancer Research, Olympus has opened the Olympus Bio Imaging Laboratory, a joint-research facility working on leading-edge cancer treatments. Olympus has also developed the RIKEN BSI-Olympus Collaboration Center, a joint R&D base equipped with the most advanced bioimaging equipment, at the Brain Science Institute at the Institute of Physical and Chemical Research (RIKEN).
The 21st century has been called the "Century of Bioscience." Through state-of-the-art technology and active collaboration with leading researchers, Olympus is making every effort to contribute to the realization of next-generation medical care optimized to the needs of every individual.
Molecular Imaging to Support the Evolution of Medical Care
The origins of Olympus stretch back to its production of microscopes in 1920. Olympus has supported many researchers around the world by incorporating new value in its microscopes, such as picture-taking and auto-focus functions, as well as the development of laser microscopes. Today, microscopes are used to observe even protein molecules and genes within cells at the nanometer level (one-millionth of a millimeter).
Enabling observation of the movements and mechanisms of molecules within living organisms, molecular imaging is one of the core components of research aimed at realizing next-generation medical care. Molecular imaging is used in research into the development and transfer mechanisms of cancer, effects and metabolism of medications, the area of the cranial nerve and regenerative medicine. Olympus is bolstering its lineup of molecular imaging equipment, including confocal laser scanning microscopes that enable 3D observation inside of living cells, in vivo laser microscopes that allow viewing of the organs, tissues and cells of small animals while they are still living, and luminescence imaging systems that make it possible to observe changes in gene expression within living cells over long time spans. By providing molecular imaging systems for a wide range of applications, Olympus is contributing to the clarification of life processes and to cutting-edge research into next-generation medical care.
Diagnostic Systems
High-precision diagnosis such as clinical analysis is the key to early diagnosis of diseases. In addition to its analytical equipment that incorporates automation and systemization technologies, Olympus also leverages its capabilities in independent development and production of reagents to provide highly precise and reliable analytical results through optimal combinations of equipment and reagents.
We have constructed a unique business model to provide comprehensive support for diagnostic operations, covering maintenance and precision management services, as well as sales and management of consumables inventory. Especially in the area of clinical analysis, which takes place round-the-clock every day of the year, we believe that our mission as a manufacturer is to provide rapid response, including in times of emergency. Olympus works fervently to optimize its systems and services. For example, in the United States, we conduct preventive maintenance services through a vast remote monitoring network.
As a leading supplier of diagnostic systems, Olympus provides systems for biochemical analysis and blood transfusion testing, and is now advancing into the area of immunological testing. Moreover, we aim to forge ahead into the business of genetic diagnostic systems in the future by leveraging our genetic and protein analysis technologies.
Note: Product names that do not indicate otherwise are the names of products sold in Japan.
*Above products' information applies only to the Japanese market.
FLUOVIEW 1000-MPE
multiphoton laser scanning microscope
OV110 in vivo
observation system
LUMINOVIEW(LV200)
luminescence imaging system
AU2700 automated
chemistry analyzer
AU3000i immunoassay
system
MF20 molecular
analysis system
End of main content
